205 related articles for article (PubMed ID: 12186157)
1. Methylenetetrahydrofolate reductase gene mutation and hyperhomocysteinemia as a risk factor for coronary heart disease in the Indian population.
Nair KG; Nair SR; Ashavaid TF; Dalal JJ; Eghlim FF
J Assoc Physicians India; 2002 May; 50 Suppl():9-15. PubMed ID: 12186157
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms in MTHFR, MS and CBS genes and homocysteine levels in a Pakistani population.
Yakub M; Moti N; Parveen S; Chaudhry B; Azam I; Iqbal MP
PLoS One; 2012; 7(3):e33222. PubMed ID: 22470444
[TBL] [Abstract][Full Text] [Related]
3. Thermolabile methylenetetrahydrofolate reductase and factor V Leiden in the risk of deep-vein thrombosis.
Kluijtmans LA; den Heijer M; Reitsma PH; Heil SG; Blom HJ; Rosendaal FR
Thromb Haemost; 1998 Feb; 79(2):254-8. PubMed ID: 9493571
[TBL] [Abstract][Full Text] [Related]
4. The high prevalence of thermolabile 5-10 methylenetetrahydrofolate reductase (MTHFR) in Italians is not associated to an increased risk for coronary artery disease (CAD).
Abbate R; Sardi I; Pepe G; Marcucci R; Brunelli T; Prisco D; Fatini C; Capanni M; Simonetti I; Gensini GF
Thromb Haemost; 1998 Apr; 79(4):727-30. PubMed ID: 9569181
[TBL] [Abstract][Full Text] [Related]
5. Genetic causes of mild hyperhomocysteinemia in patients with premature occlusive coronary artery diseases.
Tsai MY; Welge BG; Hanson NQ; Bignell MK; Vessey J; Schwichtenberg K; Yang F; Bullemer FE; Rasmussen R; Graham KJ
Atherosclerosis; 1999 Mar; 143(1):163-70. PubMed ID: 10208491
[TBL] [Abstract][Full Text] [Related]
6. Hyperhomocysteinemia, atherosclerosis and thrombosis.
Cattaneo M
Thromb Haemost; 1999 Feb; 81(2):165-76. PubMed ID: 10063987
[TBL] [Abstract][Full Text] [Related]
7. Mutation (677 C to T) in the methylenetetrahydrofolate reductase gene aggravates hyperhomocysteinemia in hemodialysis patients.
Födinger M; Mannhalter C; Wölfl G; Pabinger I; Müller E; Schmid R; Hörl WH; Sunder-Plassmann G
Kidney Int; 1997 Aug; 52(2):517-23. PubMed ID: 9264011
[TBL] [Abstract][Full Text] [Related]
8. The effect of a common methylenetetrahydrofolate reductase mutation on levels of homocysteine, folate, vitamin B12 and on the risk of premature atherosclerosis.
Verhoeff BJ; Trip MD; Prins MH; Kastelein JJ; Reitsma PH
Atherosclerosis; 1998 Nov; 141(1):161-6. PubMed ID: 9863549
[TBL] [Abstract][Full Text] [Related]
9. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase.
Frosst P; Blom HJ; Milos R; Goyette P; Sheppard CA; Matthews RG; Boers GJ; den Heijer M; Kluijtmans LA; van den Heuvel LP
Nat Genet; 1995 May; 10(1):111-3. PubMed ID: 7647779
[TBL] [Abstract][Full Text] [Related]
10. Molecular genetic aspects of hyperhomocysteinemia and its relation to folic acid.
Rozen R
Clin Invest Med; 1996 Jun; 19(3):171-8. PubMed ID: 8724820
[TBL] [Abstract][Full Text] [Related]
11. The structure and properties of methylenetetrahydrofolate reductase from Escherichia coli suggest how folate ameliorates human hyperhomocysteinemia.
Guenther BD; Sheppard CA; Tran P; Rozen R; Matthews RG; Ludwig ML
Nat Struct Biol; 1999 Apr; 6(4):359-65. PubMed ID: 10201405
[TBL] [Abstract][Full Text] [Related]
12. [Relationship between methylenetetrahydrofolate reductase gene polymorphism and coronary heart disease].
Chen B; Wang X; Yu J; Zhang G; Chen F; Den J; Fu S; Li P; Cao W; Yu H
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1998 Oct; 15(5):300-2. PubMed ID: 9758879
[TBL] [Abstract][Full Text] [Related]
13. A common mutation in the methylenetetrahydrofolate reductase gene and risk of coronary heart disease: results among U.S. men.
Verhoef P; Rimm EB; Hunter DJ; Chen J; Willett WC; Kelsey K; Stampfer MJ
J Am Coll Cardiol; 1998 Aug; 32(2):353-9. PubMed ID: 9708460
[TBL] [Abstract][Full Text] [Related]
14. Plasma homocysteine levels related to interactions between folate status and methylenetetrahydrofolate reductase: a study in 52 healthy subjects.
Zittoun J; Tonetti C; Bories D; Pignon JM; Tulliez M
Metabolism; 1998 Nov; 47(11):1413-8. PubMed ID: 9826223
[TBL] [Abstract][Full Text] [Related]
15. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations.
Jacques PF; Bostom AG; Williams RR; Ellison RC; Eckfeldt JH; Rosenberg IH; Selhub J; Rozen R
Circulation; 1996 Jan; 93(1):7-9. PubMed ID: 8616944
[TBL] [Abstract][Full Text] [Related]
16. Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease.
Kluijtmans LA; van den Heuvel LP; Boers GH; Frosst P; Stevens EM; van Oost BA; den Heijer M; Trijbels FJ; Rozen R; Blom HJ
Am J Hum Genet; 1996 Jan; 58(1):35-41. PubMed ID: 8554066
[TBL] [Abstract][Full Text] [Related]
17. Common mutation in the methylenetetrahydrofolate reductase gene offers no support for mild hyperhomocysteinemia being a causal risk factor for cardiovascular disease.
Brattström L
Circulation; 1997 Nov; 96(10):3805-7. PubMed ID: 9396508
[No Abstract] [Full Text] [Related]
18. [A hyperhomocysteinemia study in a population with a familial factor for acute myocardial infarct and sudden cardiac death at a young age].
Bollani G; Ferrari R; Bersatti F; Ferrari M; Cattaneo M; Zighetti ML; Visioli O; Assanelli D
Cardiologia; 1999 Jan; 44(1):75-81. PubMed ID: 10188334
[TBL] [Abstract][Full Text] [Related]
19. Methylenetetrahydrofolate reductase gene and coronary artery disease.
van Bockxmeer FM; Mamotte CD; Vasikaran SD; Taylor RR
Circulation; 1997 Jan; 95(1):21-3. PubMed ID: 8994411
[TBL] [Abstract][Full Text] [Related]
20. Methylenetetrahydrofolate reductase (MTHFR) mutation, homocyst(e)ine, and coronary artery disease.
Wilcken DE; Wang XL; Wilcken B
Circulation; 1997 Oct; 96(8):2738-40. PubMed ID: 9355925
[No Abstract] [Full Text] [Related]
[Next] [New Search]
